Showing results (71-80 of 102) with videos related to
Sort By:
Pageof 11
Endocrine-Related Cancer|May 6, 2022
Exploring stem cell biology in pituitary tumors and derived organoidsCharlotte Nys, Yu-Lun Lee, Heleen Roose, et al.Journal of Neuro-Oncology|June 14, 2015
Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic modelKlaus Müller, Guido Henke, Sophie Pietschmann, et al.BMJ Open|September 11, 2024
Resection versus biopsy in patients with glioblastoma (RESBIOP study): study protocol for an international multicentre prospective cohort study (ENCRAM 2202)Jasper Kees Wim Gerritsen, Jacob S Young, Sandro M Krieg, et al.Cancer Immunology, Immunotherapy : CII|April 25, 2012
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trialHilko Ardon, Stefaan W Van Gool, Tina Verschuere, et al.BMJ Open|July 22, 2021
The PROGRAM study: awake mapping versus asleep mapping versus no mapping for high-grade glioma resections: study protocol for an international multicenter prospective three-arm cohort studyJasper Kees Wim Gerritsen, Clemens Maria Franciscus Dirven, Steven De Vleeschouwer, et al.Neuro-Oncology|November 1, 2020
DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survivalJoost Dejaegher, Lien Solie, Zoé Hunin, et al.Scientific Reports|April 29, 2017
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyMatthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, et al.The Journal of Investigative Dermatology|May 25, 2012
Galectin-1 in melanoma biology and related neo-angiogenesis processesVéronique Mathieu, Elisabeth Martin de Lassalle, Jaan Toelen, et al.EMBO Molecular Medicine|October 18, 2017
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growthThomas Mathivet, Claire Bouleti, Matthias Van Woensel, et al.Neuro-Oncology Advances|December 17, 2024
Level I and II deficits-A clinical survey on international practice of awake craniotomy and definitions of postoperative "major" and "minor" deficitsManuela Vooijs, Faith C Robertson, Sarah E Blitz, et al.Pageof 11